ARCADIA BIOSCIENCES INC (RKDA) Stock Fundamental Analysis
USA - NASDAQ:RKDA - US0390143032 - Common Stock
3.58 USD
-0.08 (-2.19%)
Overall RKDA gets a fundamental rating of 4 out of 10. We evaluated RKDA against 86 industry peers in the Food Products industry. While RKDA has a great health rating, there are worries on its profitability. While showing a medium growth rate, RKDA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year RKDA has reported negative net income.
In the past year RKDA has reported a negative cash flow from operations.
In the past 5 years RKDA always reported negative net income.
In the past 5 years RKDA always reported negative operating cash flow.
1.2 Ratios
RKDA's Return On Assets of -96.75% is on the low side compared to the rest of the industry. RKDA is outperformed by 89.53% of its industry peers.
RKDA has a Return On Equity of -166.23%. This is amonst the worse of the industry: RKDA underperforms 84.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -96.75% | ||
| ROE | -166.23% | ||
| ROIC | N/A |
ROA(3y)-58.73%
ROA(5y)-43.88%
ROE(3y)-98.37%
ROE(5y)-71.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of RKDA (40.63%) is better than 93.02% of its industry peers.
In the last couple of years the Gross Margin of RKDA has grown nicely.
RKDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.63% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.63%
GM growth 5Y13.12%
2. Health
2.1 Basic Checks
RKDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RKDA has more shares outstanding
The number of shares outstanding for RKDA has been increased compared to 5 years ago.
There is no outstanding debt for RKDA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
RKDA has an Altman-Z score of -49.94. This is a bad value and indicates that RKDA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RKDA (-49.94) is worse than 95.35% of its industry peers.
There is no outstanding debt for RKDA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -49.94 |
ROIC/WACCN/A
WACC8.77%
2.3 Liquidity
RKDA has a Current Ratio of 4.12. This indicates that RKDA is financially healthy and has no problem in meeting its short term obligations.
RKDA's Current ratio of 4.12 is amongst the best of the industry. RKDA outperforms 93.02% of its industry peers.
A Quick Ratio of 3.31 indicates that RKDA has no problem at all paying its short term obligations.
RKDA has a Quick ratio of 3.31. This is amongst the best in the industry. RKDA outperforms 94.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 3.31 |
3. Growth
3.1 Past
RKDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.64%, which is quite impressive.
RKDA shows a small growth in Revenue. In the last year, the Revenue has grown by 6.81%.
RKDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.95% yearly.
EPS 1Y (TTM)54.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.44%
Revenue 1Y (TTM)6.81%
Revenue growth 3Y-9.38%
Revenue growth 5Y33.95%
Sales Q2Q%11.41%
3.2 Future
Based on estimates for the next years, RKDA will show a very strong growth in Earnings Per Share. The EPS will grow by 23.39% on average per year.
The Revenue is expected to grow by 24.10% on average over the next years. This is a very strong growth
EPS Next Y49.49%
EPS Next 2Y23.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20%
Revenue Next 2Y24.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RKDA. In the last year negative earnings were reported.
Also next year RKDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
RKDA's earnings are expected to grow with 23.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.39%
EPS Next 3YN/A
5. Dividend
5.1 Amount
RKDA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:RKDA (11/12/2025, 8:00:01 PM)
3.58
-0.08 (-2.19%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners4.33%
Inst Owner Change-0.46%
Ins Owners0.26%
Ins Owner Change0%
Market Cap4.90M
Revenue(TTM)5.41M
Net Income(TTM)-7.54M
Analysts82.86
Price Target12.24 (241.9%)
Short Float %18.86%
Short Ratio0.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)196.28%
Min EPS beat(2)102.48%
Max EPS beat(2)290.08%
EPS beat(4)2
Avg EPS beat(4)30.09%
Min EPS beat(4)-229.37%
Max EPS beat(4)290.08%
EPS beat(8)5
Avg EPS beat(8)18.89%
EPS beat(12)8
Avg EPS beat(12)16.24%
EPS beat(16)12
Avg EPS beat(16)21.69%
Revenue beat(2)0
Avg Revenue beat(2)-10.17%
Min Revenue beat(2)-10.85%
Max Revenue beat(2)-9.5%
Revenue beat(4)1
Avg Revenue beat(4)-3.32%
Min Revenue beat(4)-10.85%
Max Revenue beat(4)7.71%
Revenue beat(8)4
Avg Revenue beat(8)-0.61%
Revenue beat(12)5
Avg Revenue beat(12)-9.79%
Revenue beat(16)6
Avg Revenue beat(16)-7.11%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-4166.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.91 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.08 | ||
| P/tB | 1.09 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.25
EYN/A
EPS(NY)-2.47
Fwd EYN/A
FCF(TTM)-5.53
FCFYN/A
OCF(TTM)-5.53
OCFYN/A
SpS3.95
BVpS3.31
TBVpS3.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -96.75% | ||
| ROE | -166.23% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.63% | ||
| FCFM | N/A |
ROA(3y)-58.73%
ROA(5y)-43.88%
ROE(3y)-98.37%
ROE(5y)-71.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.63%
GM growth 5Y13.12%
F-Score2
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 0% | ||
| Cap/Sales | 0% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 3.31 | ||
| Altman-Z | -49.94 |
F-Score2
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)10.16%
Cap/Depr(5y)96.24%
Cap/Sales(3y)0.38%
Cap/Sales(5y)9.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.44%
EPS Next Y49.49%
EPS Next 2Y23.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.81%
Revenue growth 3Y-9.38%
Revenue growth 5Y33.95%
Sales Q2Q%11.41%
Revenue Next Year20%
Revenue Next 2Y24.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.8%
OCF growth 3YN/A
OCF growth 5YN/A
ARCADIA BIOSCIENCES INC / RKDA FAQ
Can you provide the ChartMill fundamental rating for ARCADIA BIOSCIENCES INC?
ChartMill assigns a fundamental rating of 4 / 10 to RKDA.
Can you provide the valuation status for ARCADIA BIOSCIENCES INC?
ChartMill assigns a valuation rating of 1 / 10 to ARCADIA BIOSCIENCES INC (RKDA). This can be considered as Overvalued.
Can you provide the profitability details for ARCADIA BIOSCIENCES INC?
ARCADIA BIOSCIENCES INC (RKDA) has a profitability rating of 1 / 10.
What is the expected EPS growth for ARCADIA BIOSCIENCES INC (RKDA) stock?
The Earnings per Share (EPS) of ARCADIA BIOSCIENCES INC (RKDA) is expected to grow by 49.49% in the next year.